Welcome To AcelaBio
AcelaBio is a state-of-the-art contract research organization delivering end-to-end histopathology and precision medicine laboratory services for pharmaceutical, biotech, and academic institutions.
AcelaBio's expert team is made up of operational, scientific, and medical experts, including U.S. Board Certified pathologists, dedicated to delivering reliable, high-quality data and imagery.
As a CAP-accredited laboratory, AcelaBio has rigorous policies and procedures for optimizing and validating assays to ensure high-quality laboratory testing and patient safety.
AcelaBio provides high throughput digital pathology services to support multicenter, global clinical trials and has the flexibility to develop and validate biomarker assays for novel or existing protein or molecular targets.
Services
AcelaBio provides end-to-end histopathology and precision medicine services from "sample-to-score" for clinical trials and clinical research, including:
- Accessioning
- Processing
- Embedding
- Sectioning
- Hematoxylin & Eosin
- Special Stains
- In Situ Hybridization
- Antibody Optimization
- Assay Development
- Immunostaining
- Whole Slide Imaging
- Storage & Archiving
- Pathology Review
- Data Management
- Sample Logistics
- Consulting
- Project Management
- Clinical Trial Support
- RNA Extraction*
- Spatial Transcriptomics*
- Bioinformatics*
- Digital Image Analysis*
*For Research Use Only (not for use in diagnostic procedures)
Therapeutic Areas
We focus on providing end-to-end histopathology and precision medicine services to support clinical research in areas of oncology, dermatology, and gastrointestinal diseases, with extensive experience in inflammatory bowel disease (IBD), nonalcoholic steatohepatitis (NASH), eosinophilic gastrointestinal diseases (EGID), and celiac disease (CeD)
0
Whole Slide Images
0
Projects
0